BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 23117949)

  • 1. Myotonic dystrophy: from bench to bedside.
    Johnson NE; Heatwole CR
    Semin Neurol; 2012 Jul; 32(3):246-54. PubMed ID: 23117949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Myotonic dystrophies: clinical presentation, pathogenesis, diagnostics and therapy].
    Finsterer J; Rudnik-Schöneborn S
    Fortschr Neurol Psychiatr; 2015 Jan; 83(1):9-17. PubMed ID: 25602187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severity, type, and distribution of myotonic discharges are different in type 1 and type 2 myotonic dystrophy.
    Logigian EL; Ciafaloni E; Quinn LC; Dilek N; Pandya S; Moxley RT; Thornton CA
    Muscle Nerve; 2007 Apr; 35(4):479-85. PubMed ID: 17230537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral involvement in myotonic dystrophies.
    Meola G; Sansone V
    Muscle Nerve; 2007 Sep; 36(3):294-306. PubMed ID: 17486579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical aspects, molecular pathomechanisms and management of myotonic dystrophies.
    Meola G
    Acta Myol; 2013 Dec; 32(3):154-65. PubMed ID: 24803843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscle pathology in myotonic dystrophy: light and electron microscopic investigation in eighteen patients.
    Nadaj-Pakleza A; Lusakowska A; Sułek-Piątkowska A; Krysa W; Rajkiewicz M; Kwieciński H; Kamińska A
    Folia Morphol (Warsz); 2011 May; 70(2):121-9. PubMed ID: 21630234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct pathological signatures in human cellular models of myotonic dystrophy subtypes.
    Kim EY; Barefield DY; Vo AH; Gacita AM; Schuster EJ; Wyatt EJ; Davis JL; Dong B; Sun C; Page P; Dellefave-Castillo L; Demonbreun A; Zhang HF; McNally EM
    JCI Insight; 2019 Mar; 4(6):. PubMed ID: 30730308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of MTMR1 expression and correlation with muscle pathological features in juvenile/adult onset myotonic dystrophy type 1 (DM1) and in myotonic dystrophy type 2 (DM2).
    Santoro M; Modoni A; Masciullo M; Gidaro T; Broccolini A; Ricci E; Tonali PA; Silvestri G
    Exp Mol Pathol; 2010 Oct; 89(2):158-68. PubMed ID: 20685272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myotonic dystrophies.
    Huang CC; Kuo HC
    Chang Gung Med J; 2005 Aug; 28(8):517-26. PubMed ID: 16265841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subtle cognitive dysfunction in adult onset myotonic dystrophy type 1 (DM1) and type 2 (DM2).
    Gaul C; Schmidt T; Windisch G; Wieser T; Müller T; Vielhaber S; Zierz S; Leplow B
    Neurology; 2006 Jul; 67(2):350-2. PubMed ID: 16864839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myotonic dystrophy type 2 and modifier genes: an update on clinical and pathomolecular aspects.
    Meola G; Cardani R
    Neurol Sci; 2017 Apr; 38(4):535-546. PubMed ID: 28078562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA pathogenesis of the myotonic dystrophies.
    Day JW; Ranum LP
    Neuromuscul Disord; 2005 Jan; 15(1):5-16. PubMed ID: 15639115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myotonic dystrophies type 1 and 2: a summary on current aspects.
    Schara U; Schoser BG
    Semin Pediatr Neurol; 2006 Jun; 13(2):71-9. PubMed ID: 17027856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics of myotonic dystrophy type 1 patients with small CTG expansions.
    Arsenault ME; Prévost C; Lescault A; Laberge C; Puymirat J; Mathieu J
    Neurology; 2006 Apr; 66(8):1248-50. PubMed ID: 16636244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pathogenesis of myotonic dystrophy type 1].
    Magaña JJ; Leyva-García N; Cisneros B
    Gac Med Mex; 2009; 145(4):331-7. PubMed ID: 20073433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and molecular aspects of the myotonic dystrophies: a review.
    Machuca-Tzili L; Brook D; Hilton-Jones D
    Muscle Nerve; 2005 Jul; 32(1):1-18. PubMed ID: 15770660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myotonic dystrophies type 1 and 2: anesthetic care.
    Veyckemans F; Scholtes JL
    Paediatr Anaesth; 2013 Sep; 23(9):794-803. PubMed ID: 23384336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and Validation of a New Molecular Diagnostic Assay for Detection of Myotonic Dystrophy Type 2.
    Valaperta R; Lombardi F; Cardani R; Fossati B; Brigonzi E; Merli I; Sansone V; Merletti G; Spina E; Meola G; Costa E
    Genet Test Mol Biomarkers; 2015 Dec; 19(12):703-9. PubMed ID: 26505324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A non-DM1, non-DM2 multisystem myotonic disorder with frontotemporal dementia: phenotype and suggestive mapping of the DM3 locus to chromosome 15q21-24.
    Le Ber I; Martinez M; Campion D; Laquerrière A; Bétard C; Bassez G; Girard C; Saugier-Veber P; Raux G; Sergeant N; Magnier P; Maisonobe T; Eymard B; Duyckaerts C; Delacourte A; Frebourg T; Hannequin D
    Brain; 2004 Sep; 127(Pt 9):1979-92. PubMed ID: 15215218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cardiac, respiratory and sleep disorders in patients with myotonic dystrophy].
    Banach M; Rakowicz M; Antczak J; Rola R; Witkowski G; Waliniowska E
    Przegl Lek; 2009; 66(12):1065-8. PubMed ID: 20514907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.